Metsera Inc (MTSR) USD0.00001
Sell:$17.55Buy:$18.75
$2.65
(12.51%)
1.26%- This stock can be held in a
Stocks and Shares ISA$2.65
(12.51%)$2.65
(12.51%)Company Information
About this company
Metsera Inc is a United States-based biopharmaceutical company. The Company is engaged in developing medicines and solutions for obesity and metabolic diseases. It offers a broad portfolio of oral and injectable incretin, non-incretin and combination therapies with profiles to address multiple therapeutic targets and meet the future needs of a weight loss treatment landscape. Its solutions helps to reduce the physical, emotional, and economic burdens of obesity as a driver of diseases. In addition it offers HALO, which is a peptide lipidation platform technology, which enables peptides to bind simultaneously to albumin and to a drug target.
Key people
Key facts
- EPICMTSR
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINUS59267L1070
- Market cap$2.48bn
- Employees74
- Shares in issue105.05m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.